Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Total Liabilities (2016 - 2025)

STRATA Skin Sciences' Total Liabilities history spans 15 years, with the latest figure at $27.6 million for Q4 2025.

  • On a quarterly basis, Total Liabilities fell 7.82% to $27.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $27.6 million, a 7.82% decrease, with the full-year FY2025 number at $27.6 million, down 7.82% from a year prior.
  • Total Liabilities hit $27.6 million in Q4 2025 for STRATA Skin Sciences, down from $29.4 million in the prior quarter.
  • Over the last five years, Total Liabilities for SSKN hit a ceiling of $38.3 million in Q2 2023 and a floor of $19.1 million in Q2 2021.
  • Historically, Total Liabilities has averaged $28.5 million across 5 years, with a median of $29.8 million in 2023.
  • Biggest five-year swings in Total Liabilities: skyrocketed 63.6% in 2022 and later decreased 23.61% in 2024.
  • Tracing SSKN's Total Liabilities over 5 years: stood at $21.2 million in 2021, then surged by 43.73% to $30.4 million in 2022, then decreased by 3.66% to $29.3 million in 2023, then rose by 2.14% to $30.0 million in 2024, then decreased by 7.82% to $27.6 million in 2025.
  • Business Quant data shows Total Liabilities for SSKN at $27.6 million in Q4 2025, $29.4 million in Q3 2025, and $29.0 million in Q2 2025.